Lipid formulated dsRNA targeting the PCSK9 gene

Details for Australian Patent Application No. 2010260148 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Fitzgerald, Kevin; Hinkle, Gregory; Akinc, Akin; Milstein, Stuart

Agent FB Rice

Pub. Number AU-A-2010260148

PCT Pub. Number WO2010/148013

Priority 61/244,790 22.09.09 US; 61/218,350 18.06.09 US; 61/187,169 15.06.09 US; 61/293,474 08.01.10 US; 61/313,578 12.03.10 US; 61/285,598 11.12.09 US

Filing date 15 June 2010

Wipo publication date 23 December 2010

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/148013 Priority application(s): WO2010/148013

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010260149-Side-by-side vehicle

2010260146-Crossbar clamp devices